Clearmind Medicine CMND
NASDAQ CMND
$6.00 +0.01 (+0.08%)
As of: Oct 22, 2026 · 10:25 AM EDT

Clearmind Medicine (CMND) EBIT Margin (2023 - 2025)

Updated

Clearmind Medicine (CMND) recorded EBIT Margin of -4180.53% in FY2022 (year ended Oct 31, 2022), down 1568.02 percentage points from -2612.51% in FY2021.

Analysis

Clearmind Medicine (CMND) EBIT Margin (2023 - 2025) Analysis & Trends

  • Per Business Quant data, CMND's EBIT Margin was -2612.51% in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,176.80 Bn 1,145.39 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn 28.21%
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn 37.86%
4 Merck 376.70 Bn 331.08 Bn 12.21 Bn -3.52%
5 Novartis Ag 303.61 Bn 267.60 Bn 11.24 Bn 32.97%
6 Astrazeneca 268.37 Bn 242.05 Bn 12.86 Bn 20.57%
7 Amgen 242.34 Bn 197.74 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.58 Bn 167.78 Bn 6.22 Bn -133.21%
9 Pfizer 172.88 Bn 119.53 Bn 10.94 Bn 28.37%
10 Clearmind Medicine 9,534.00 -39.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2025 -88.97%
Jul 31, 2025 -1,274.37%
Jan 31, 2025 -222.53%
Oct 31, 2024 -98.63%
Apr 30, 2024 -201.71%
Jul 31, 2023 -111.66%
Apr 30, 2023 -34,648.26%
Jan 31, 2023 -6,703.75%
API Access

Clearmind Medicine EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=CMND&period=max&api_key=YOUR_API_KEY